Evidence map›Paper›PMID 11156533›Full record

ArticleAmerican journal of human genetics2001

Bilineal disease and trans-heterozygotes in autosomal dominant polycystic kidney disease.

Y Pei, A D Paterson, K R Wang, N He, D Hefferton, T Watnick, G G Germino, P Parfrey, S Somlo, P St George-Hyslop

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 158 citations in OpenAlex.

  1. Molecular diagnostics in autosomal dominant polycystic kidney disease: utility and limitations.Clinical journal of the American Society of Nephrology : CJASN · 2008
    Trial
  2. Article
  3. Review
  4. Article
  5. Patients with Protein-TruncatingClinical journal of the American Society of Nephrology : CJASN · 2021
    Article
  6. Targeted broad-based genetic testing by next-generation sequencing informs diagnosis and facilitates management in patients with kidney diseases.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2021
    Article
  7. Review
  8. Article
  9. Article
  10. Examining the Role of Polymorphisms in Exon 25 of theReports of biochemistry & molecular biology · 2019
    Article
  11. Polycystic kidney disease.Nature reviews. Disease primers · 2018
    Review
  12. Article
  13. Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing.Journal of the American Society of Nephrology : JASN · 2018
    Article
  14. Article
  15. Article
  16. The Value of Genetic Testing in Polycystic Kidney Diseases Illustrated by a Family With PKD2 and COL4A1 Mutations.American journal of kidney diseases : the official journal of the National Kidney Foundation · 2018
    Article
  17. Article
  18. Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases.Journal of the American Society of Nephrology : JASN · 2018
    Review
  19. Review
  20. Polycystic Kidney Disease without an Apparent Family History.Journal of the American Society of Nephrology : JASN · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 2 countries.

Y PeiDivision of Genomic Medicine, Department of Medicine, University Health Network, Toronto, Ontario, Canada. york.pei@uhn.on.ca
A D Paterson
K R Wang
N He
D Hefferton
T Watnick
G G Germino
P Parfrey
S Somlo
P St George-Hyslop
University Health Network · CAJohns Hopkins University · USSt. John's University · USHospital for Sick Children · CAYale University · US

Funding

YALE CENTER FOR THE STUDY OF POLYCYSTIC KIDNEY DISEASEP50DK057328 · NIDDK · YALE UNIVERSITY · PI SOMLO, STEFAN · 1999 to 2009
$11.1M
6 · The paper itself

Abstract

In searching for a putative third gene for autosomal dominant polycystic kidney disease (ADPKD), we studied the genetic inheritance of a large family (NFL10) previously excluded from linkage to both the PKD1 locus and the PKD2 locus. We screened 48 members of the NFL10 pedigree, by ultrasonography, and genotyped them, with informative markers, at both the PKD1 locus and the PKD2 locus. Twenty-eight of 48 individuals assessed were affected with ADPKD. Inspection of the haplotypes of these individuals suggested the possibility of bilineal disease from independently segregating PKD1 and PKD2 mutations. Using single-stranded conformational analysis, we screened for and found a PKD2 mutation (i.e., 2152delA; L736X) in 12 affected pedigree members. Additionally, when the disease status of these individuals was coded as "unknown" in linkage analysis, we also found, with markers at the PKD1 locus, significant LOD scores (i.e., >3.0). These findings strongly support the presence of a PKD1 mutation in 15 other affected pedigree members, who lack the PKD2 mutation. Two additional affected individuals had trans-heterozygous mutations involving both genes, and they had renal disease that was more severe than that in affected individuals who had either mutation alone. This is the first documentation of bilineal disease in ADPKD. In humans, trans-heterozygous mutations involving both PKD1 and PKD2 are not necessarily embryonically lethal. However, the disease associated with the presence of both mutations appears to be more severe than the disease associated with either mutation alone. The presence of bilineal disease as a confounder needs to be considered seriously in the search for the elusive PKD3 locus.

Indexed as

Genes, DominantAmino Acid SequenceBase SequenceDNADNA Mutational AnalysisFamily HealthFemaleGenotypeHaplotypesHeterozygoteHumansLod ScoreMaleMembrane ProteinsMolecular Sequence DataMutationDNAMembrane ProteinsProteinsTRPP Cation Channels

Identifiers

PMID11156533
PMCPMC1235269
OpenAlexW2070588709

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.